Clinical Trials Logo

Clinical Trial Summary

This study evaluated the analgesic efficacy of fentanyl and dexamethasone in combination with bupivacaine for single-shot paravertebral block (PVB) in patients undergoing major breast surgery.


Clinical Trial Description

This study evaluated the analgesic efficacy of fentanyl and dexamethasone in combination with bupivacaine for single-shot paravertebral block (PVB) in patients undergoing major breast surgery. Patients will receive ultrasound guided paravertebral block and stratified into 3 groups according to medication used : Group 1 : bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg Group 2 : bupivacaine (0.5%) 20 ml , dexamethasone 4 mg Group 2 : bupivacaine (0.5%) 20 ml , fentanyl 1 μg/kg , dexamethasone 4 mg ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03480308
Study type Interventional
Source Assiut University
Contact Amonios khalil
Phone 01023466456
Email amonios_khalil@yahoo.com
Status Recruiting
Phase N/A
Start date April 1, 2018
Completion date March 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT04078347 - Infrared Thermography to Evaluate the Effect of Paravertebral Block
Recruiting NCT05896150 - Intercostal Cryoanalgesia for Acute Pain After VATS Lung Resection N/A
Not yet recruiting NCT06082206 - Pectoral Nerve Block Versus Paravertebral Block In The Incidence of Chronic Pain After Mastectomy: N/A
Recruiting NCT06426706 - TPVB or SPSIPB in Pain Management After VATS N/A
Completed NCT04304274 - Programmed Intermittent Bolus Infusion of Thoracic Paravertebral Block for Hepatectomy N/A
Completed NCT03990922 - CTPVB for Hepatectomy N/A
Completed NCT05713643 - ESPB vs PVB vs QLB After Pelvi-ureteric Surgeries N/A
Recruiting NCT06231355 - Liposomal vs. Conventional Bupivacaine for Pain Control Phase 4
Enrolling by invitation NCT05822076 - Influence of Thoracic Paravertebral Block on Cardiac Repolarization
Completed NCT06011746 - Adding Ketamine to Levobupivacaine in Paravertebral Block in Thoracotomy Phase 4
Not yet recruiting NCT05816538 - The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks N/A